Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination for the treatment of people living with HIV in Argentina: first interim report of the BICTARG cohort
Cecchini et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Efficacy and Safety of Switching Older Adults (≥60 Years) from First-Line ART to B/F/TAF in Kenya
A Randomized Clinical Trial (the B/F/TAF Elderly Study)
Ombajo et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials
Sax P et al.

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

GOING BEYOND
Tackling HIV, together

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

GOING BEYOND
Tackling HIV, together

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Association of remdesivir with hospital readmissions in COVID-19 patients admitted to the ICU while Delta and Omicron were the predominant circulating variants

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Remdesivir reduces readmission in immunocompromised adult patients hospitalised with COVID-19

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Remdesivir is associated with lower mortality in cancer patients hospitalized for COVID-19 across emerging variants

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Immunocompromised patients hospitalized for COVID-19 in the United States: evolving patient characteristics and clinical outcomes across emerging variants

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Framingham on HIV / AIDS issue 2 – 2023

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Remdesivir is associated with reduced readmission after COVID-19 hospitalization Mozaffari et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...

Remdesivir reduces mortality in hospitalized COVID-19 patients across variant eras Mozaffari et al

  This content is only accessible to healthcare professionals in Belgium.   To view our restricted content please register HERE. You will be granted immediate access. If you are already registered, please sign-in HERE. To register as a Gilead employee,...